Takeda Pharmaceutical Co (TAK) ADR Each Repr 0.5 Share Sponsored
Sell:$14.06Buy:$14.07
$0.20
(1.44%)
- This stock can be held in a
Stocks and Shares ISA$0.20
(1.44%)$0.20
(1.44%)Company Information
About this company
Takeda Pharmaceutical Company Limited is a Japan-based company mainly engaged in the pharmaceutical business. The Company is engaged in the research, development, manufacture and sale of pharmaceutical products, General medical products, quasi drugs and healthcare products in Japan and overseas. The Company's research and development functions are concentrated in four areas of oncology (cancer), digestive system diseases, rare diseases and neurology (neuropsychiatric diseases), as well as two business units of plasma fractionation products and vaccines. The Company is engaged in the improvement of pipelines at research and development centers located mainly in Japan and the United States.
Key people
Key facts
- EPIC-
- LocationJapan
- SectorHealthcare
- IndustryBiotechnology & Drugs
- ISINUS8740602052
- Market cap$43.76bn
- Employees49,281
- Shares in issue1.59bn
- ExchangeTokyo Stock Exchange
- IndexNikkei 225 Index, TOPIX Stock Price Index
- Website
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.